Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Volitionrx (VNRX) Non-Current Deffered Revenue (2024 - 2025)

Historic Non-Current Deffered Revenue for Volitionrx (VNRX) over the last 2 years, with Q3 2025 value amounting to $22.0 million.

  • Volitionrx's Non-Current Deffered Revenue changed N/A to $22.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.0 million, marking a year-over-year change of. This contributed to the annual value of $22.7 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that Volitionrx reported Non-Current Deffered Revenue of $22.0 million as of Q3 2025.
  • In the past 5 years, Volitionrx's Non-Current Deffered Revenue ranged from a high of $22.7 million in Q4 2024 and a low of $22.0 million during Q3 2025